Healthcare >> Analyst Interviews >> November 14, 2011
Innovation Is Key Theme In Biotechnology – Ravi Mehrotra – Credit Suisse
Ravi Mehrotra, Ph.d, is Head of Global Biotechnology Research at Credit Suisse, based in New York since August 2010. Dr. Mehrotra joined Credit Suisse London in June 2004 as Head of European Biotechnology Research. In the most recent 2010 European Institutional Investor and Extel surveys, he was ranked number one having achieved at least runner-up positions since joining Credit Suisse. Dr. Mehrotra also co-covers the EMEA generics sector. Previously, he held a similar role at SG Cowen from 1999 to 2004 and also has covered the pharmaceuticals sector for Deutsche Bank Alex.Brown from 1997 to 1999. His academic qualifications include a B.Sc. with honors and a Ph.D. in biochemistry and molecular biology from The University of Manchester. Profile
TWST: What is your coverage within biotech?
Dr. Mehrotra: I've been a sell-side Research Analyst for 15 years. In that time, I've covered numerous sectors within the health care industry, including